Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1):: restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF3 cells overexpressing bcl2

被引:24
|
作者
Quash, G
Fournet, G
Chantepie, J
Gore, J
Ardiet, C
Ardail, D
Michal, Y
Reichert, U
机构
[1] Fac Med Lyon Sud, INSERM, U329, Lab Immunochim, F-69921 Oullins, France
[2] CNRS, CPE, UMR 5622, Lab Chim Organ 1, F-69622 Villeurbanne, France
[3] Ctr Leon Berard, Lab Pharmacocinet, F-69373 Lyon 08, France
[4] Fac Med Lyon Sud, INSERM, U189, Biochim Lab, F-69921 Oullins, France
[5] Galderma R&D, F-06902 Valbonne, France
关键词
ALDH1; thiolester inhibitors; chemoresistance; bcl(2); apoptosis;
D O I
10.1016/S0006-2952(02)01294-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
4-Amino-4-methyl-pent-2-ynthioc acid S-methyl ester (ampal thiolester: ATE) was used as a lead compound to synthesise new aminosubstituted derivatives of alpha,beta acetylenic thiolester compounds as inhibitors of aldehyde dehydrogenase 1, (ALDH1). Of these compounds, the dimethyl derivative (DIMATE) was a competitive irreversible inhibitor (K-i similar to 280 muM) of baker's yeast ALDH1 in vitro showing 80% inhibition at 400 muM when preincubated with the enzyme for 30 min, whereas the trimethyl ammonium and the morpholine derivatives showed only 15% inhibition at 600 muM even after 60 min preincubation. ATE inhibited ALDH1 activity in ALDH1-transfected L1210 T cells resistant to hydroperoxycyclophosphamide (HCPA) and inhibited growth synergistically in the presence of HCPA. In non-transfected L1210 counterparts ATE did not potentiate growth inhibition by HCPA. DIMATE was a 30-100-fold more effective growth inhibitor than ATE. Endogenous ALDH1 activities of BAF(3) cells over-expressing different levels of bcl(2) (0-100%) were similar (16-20 mU/mg protein) and were all inhibited by DIMATE, reaching 20-30% at 4 muM. Up to 4 muM no apoptosis, as measured by DNA-fragmentation was observed, but at 8 and 10 muM DIMATE, DNA-fragmentation increased concomitantly with ALDH1 inhibition. No DNA-fragmentation was observed with ALDH1 irreversible inhibitors devoid of a thiolester group or with thiolesters which were not inhibitors of ALDH1. It was seen only with competitive irreversible inhibitors having the methanethiol and enzyme-inhibitory moieties. The methanethiol putatively released from DIMATE by ALDH1 esterase activity plays a role, albeit undefined, in lowering intramitochondrial glutathione levels which decreased by 47% as DNA-fragmentation increased. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1279 / 1292
页数:14
相关论文
共 4 条
  • [1] Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLC
    MacDonagh, L.
    Gray, S. G.
    Cuffe, S.
    Finn, S. P.
    O'Byrne, K. J.
    Barr, M. P.
    LUNG CANCER, 2016, 91 : S3 - S3
  • [2] Aldehyde Dehydrogenase 1 (ALDH1) Is a Novel Marker for Tumor-Associated Macrophages and Dendritic Cells in Mature B-Cell Lymphomas
    Leventaki, V.
    Kunkalla, K.
    Liu, Y.
    Qu, C.
    Agarwal, N. K.
    Medeiros, J. L.
    Vega-Vazquez, F.
    MODERN PATHOLOGY, 2013, 26 : 341A - 341A
  • [3] Aldehyde Dehydrogenase 1 (ALDH1) Is a Novel Marker for Tumor-Associated Macrophages and Dendritic Cells in Mature B-Cell Lymphomas
    Leventaki, V.
    Kunkalla, K.
    Liu, Y.
    Qu, C.
    Agarwal, N. K.
    Medeiros, J. L.
    Vega-Vazquez, F.
    LABORATORY INVESTIGATION, 2013, 93 : 341A - 341A
  • [4] Cancer Stem Cells: Targeting Aldehyde Dehydrogenase 1 (ALDH1) as a Novel Strategy in Cisplatin Resistant Non-Small Cell Lung Cancer?
    Mac Donagh, Lauren
    Gray, Steven G.
    O'Byrne, KennethJ.
    Cuffe, Sinead
    Finn, Stephen P.
    Barr, Martin P.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S258 - S258